EOS:减肥手术可降低肥胖者死亡风险你造么?!

2016-06-06 QQduhq 译 MedSci原创

在当今社会,肥胖症患者人数越来越多,肥胖已经是一个新兴的健康问题和导致死亡的重要因素。由于超重和肥胖的人越来越多,因此现在减肥手术日渐盛行。几项研究已经显示,实施减肥手术不仅可帮助患者减肥,也可增加一个人的寿命。现在更多的证据表明,减肥手术可能会大大降低肥胖民众过早死亡的风险。 最近的一项研究中,瑞典研究人员发现,肥胖的人接受减肥手术后在5年内死亡风险较低。 瑞典哥德堡大学的Christina P

在当今社会,肥胖症患者人数越来越多,肥胖已经是一个新兴的健康问题和导致死亡的重要因素。由于超重和肥胖的人越来越多,因此现在减肥手术日渐盛行。几项研究已经显示,实施减肥手术不仅可帮助患者减肥,也可增加一个人的寿命。现在更多的证据表明,减肥手术可能会大大降低肥胖民众过早死亡的风险。 


最近的一项研究中,瑞典研究人员发现,肥胖的人接受减肥手术后在5年内死亡风险较低。
 
瑞典哥德堡大学的Christina Persson和同事对48693名年龄范围为18-74岁的肥胖患者进行了调查。其中22581人于2000-2011年接受减肥手术,92.8%的肥胖者接受胃旁路手术。并与26112名未接受这些手术的民众进行了对比研究。

结果显示,与不接受手术的肥胖者相比,接受减肥手术的患者总体死亡率下降了57%。调整年龄、心血管疾病、癌症和糖尿病等因素后结论依旧成立。 

不接受手术的肥胖者死亡率更高,5年内死亡人数增加了4.21%,相当于每年1000名肥胖者中有7.7人因肥胖或其他原因死亡。对于接受手术的肥胖者而言死亡率则较低,相当于每年1000人中有2.1人因各种原因死亡。不接受减肥手术的肥胖者的死亡原因最常见于肿瘤、心血管疾病;接受减肥手术的肥胖者最常见的死亡原因是交通事故和自杀,其次是心血管疾病和肿瘤。

这项研究表明,肥胖者接受减肥手术可大大降低患者的全因死亡率。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=141604, encodeId=d02a141604a4, content=顶起, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/24/1d5475965cdc40d3133b065415eb11f2.jpg, createdBy=9c1c1689676, createdName=葫芦小金刚h, createdTime=Sat Oct 08 00:34:16 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132213, encodeId=a598132213d1, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:58:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=128512, encodeId=b11c12851285, content=不错哦,会学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 16 09:40:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127492, encodeId=8dba12e492ae, content=也是一种选择, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 14:06:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926718, encodeId=a0d51926e1895, content=<a href='/topic/show?id=7ecd81935b4' target=_blank style='color:#2F92EE;'>#肥胖者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81935, encryptionId=7ecd81935b4, topicName=肥胖者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Sun Apr 16 14:37:00 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255565, encodeId=46f41255565d7, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Jun 07 23:37:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-10-08 葫芦小金刚h

    顶起

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=141604, encodeId=d02a141604a4, content=顶起, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/24/1d5475965cdc40d3133b065415eb11f2.jpg, createdBy=9c1c1689676, createdName=葫芦小金刚h, createdTime=Sat Oct 08 00:34:16 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132213, encodeId=a598132213d1, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:58:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=128512, encodeId=b11c12851285, content=不错哦,会学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 16 09:40:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127492, encodeId=8dba12e492ae, content=也是一种选择, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 14:06:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926718, encodeId=a0d51926e1895, content=<a href='/topic/show?id=7ecd81935b4' target=_blank style='color:#2F92EE;'>#肥胖者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81935, encryptionId=7ecd81935b4, topicName=肥胖者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Sun Apr 16 14:37:00 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255565, encodeId=46f41255565d7, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Jun 07 23:37:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-09-21 1e10c84am36(暂无匿称)

    文章很好,非常有益

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=141604, encodeId=d02a141604a4, content=顶起, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/24/1d5475965cdc40d3133b065415eb11f2.jpg, createdBy=9c1c1689676, createdName=葫芦小金刚h, createdTime=Sat Oct 08 00:34:16 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132213, encodeId=a598132213d1, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:58:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=128512, encodeId=b11c12851285, content=不错哦,会学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 16 09:40:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127492, encodeId=8dba12e492ae, content=也是一种选择, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 14:06:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926718, encodeId=a0d51926e1895, content=<a href='/topic/show?id=7ecd81935b4' target=_blank style='color:#2F92EE;'>#肥胖者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81935, encryptionId=7ecd81935b4, topicName=肥胖者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Sun Apr 16 14:37:00 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255565, encodeId=46f41255565d7, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Jun 07 23:37:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-09-16 1e10c84am36(暂无匿称)

    不错哦,会学到很多

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=141604, encodeId=d02a141604a4, content=顶起, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/24/1d5475965cdc40d3133b065415eb11f2.jpg, createdBy=9c1c1689676, createdName=葫芦小金刚h, createdTime=Sat Oct 08 00:34:16 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132213, encodeId=a598132213d1, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:58:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=128512, encodeId=b11c12851285, content=不错哦,会学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 16 09:40:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127492, encodeId=8dba12e492ae, content=也是一种选择, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 14:06:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926718, encodeId=a0d51926e1895, content=<a href='/topic/show?id=7ecd81935b4' target=_blank style='color:#2F92EE;'>#肥胖者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81935, encryptionId=7ecd81935b4, topicName=肥胖者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Sun Apr 16 14:37:00 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255565, encodeId=46f41255565d7, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Jun 07 23:37:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-09-15 舒心和人

    也是一种选择

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=141604, encodeId=d02a141604a4, content=顶起, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/24/1d5475965cdc40d3133b065415eb11f2.jpg, createdBy=9c1c1689676, createdName=葫芦小金刚h, createdTime=Sat Oct 08 00:34:16 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132213, encodeId=a598132213d1, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:58:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=128512, encodeId=b11c12851285, content=不错哦,会学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 16 09:40:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127492, encodeId=8dba12e492ae, content=也是一种选择, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 14:06:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926718, encodeId=a0d51926e1895, content=<a href='/topic/show?id=7ecd81935b4' target=_blank style='color:#2F92EE;'>#肥胖者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81935, encryptionId=7ecd81935b4, topicName=肥胖者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Sun Apr 16 14:37:00 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255565, encodeId=46f41255565d7, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Jun 07 23:37:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2017-04-16 chg121
  6. [GetPortalCommentsPageByObjectIdResponse(id=141604, encodeId=d02a141604a4, content=顶起, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/24/1d5475965cdc40d3133b065415eb11f2.jpg, createdBy=9c1c1689676, createdName=葫芦小金刚h, createdTime=Sat Oct 08 00:34:16 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132213, encodeId=a598132213d1, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:58:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=128512, encodeId=b11c12851285, content=不错哦,会学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 16 09:40:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127492, encodeId=8dba12e492ae, content=也是一种选择, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 14:06:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926718, encodeId=a0d51926e1895, content=<a href='/topic/show?id=7ecd81935b4' target=_blank style='color:#2F92EE;'>#肥胖者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81935, encryptionId=7ecd81935b4, topicName=肥胖者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Sun Apr 16 14:37:00 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255565, encodeId=46f41255565d7, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Jun 07 23:37:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]

相关资讯

AACE/ACE联合怒推《肥胖患者综合治疗临床实践指南》

2016年美国临床内分泌医师协会(AACE)年会上宣布,AACE与美国内分泌协会(ACE)联合制定的《肥胖患者综合治疗临床实践指南》已于5月24日在线发表于AACE的官方杂志Endocrine Practice。

ASCO 2016:转移性结直肠癌患者BMI越高,生存越好?

ASCO年会上的一项荟萃分析结果显示,与正常体重患者相比,超重和肥胖的转移性结直肠癌患者有更长的OS。此外BMI<18.5的患者经历了显着恶化的OS和PFS。来自法国Avicenne医院的Thomas Aparicio博士说:“我们的分析结果证实了先前的研究结果,肥胖提高转移性结直肠癌患者的生存。值得注意的是,贝伐单抗对肥胖和非肥胖患者的有效性是一致的,但改善肥胖患者预后的原因仍然是未知的;有人认

国际糖尿病指南百年来最猛改动!

近日,Nature发表评论称,糖尿病治疗指南史发生百年来最猛更改:把外科手术治疗方式正式写入治疗指南!

ECE 2106:联合胃和肠道的减肥手术对糖尿病患者更有益

欧洲内分泌学大会上称,肥胖和2型糖尿病患者经历改道胃袖状切除回肠换位或迷你胃旁路手术,与袖状胃切除术患者相比,30天后的血糖控制情况更佳。伊斯坦布尔代谢外科诊所的医疗主任Alper Celik博士道,“许多肥胖的糖尿病患者仅靠药物是不能很好的控制血糖的, 我们进行了一项前瞻性队列研究,比较三种不同减肥手术方案,对患者术后30天的血糖控制的影响。”该研究纳入了251名2型糖尿病和肥胖患者(平均年龄5

ECE 2016:减肥手术可改善2型糖尿病患者的神经病变

欧洲内分泌学大会上公布结果显示,血糖控制不佳的2型糖尿病和肥胖患者在经历腹腔镜回肠转位袖状胃切除术后1个月,其糖尿病神经病变症状显著改善。“所谓的“不可逆”的糖尿病神经病变是可逆的,”伊斯坦布尔代谢外科诊所的医疗主任Alper Celik博士说,“几乎三分之二的患者在代谢手术后糖尿病神经病变得到改善,不管术后体重和血糖控制的变化。”这项横断面非盲的前瞻性研究纳入了55名血糖控制不佳的2型糖尿病和肥